Biotechnology Stocks
| # | Letzte 7 Tage | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3228 | IMRX Immuneering Corporation - Class A Common Stock | 5.21 USD | -1.70% | +2.36% | +18.95% | +8.54% | 337.07 M USD | ||
| 3239 | STRO Sutro Biopharma, Inc. - Common Stock | 20.25 USD | -3.75% | -2.69% | -11.88% | +16.45% | 335.77 M USD | ||
| 3240 | YDES YD Bio Limited - Ordinary Shares | 4.77 USD | +1.71% | +48.14% | +115.84% | -40.38% | 337.66 M USD | ||
| 3254 | OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 5.46 USD | +1.87% | +20.53% | +43.68% | +114.12% | 328.17 M USD | ||
| 3275 | IRD Opus Genetics, Inc. - Common Stock | 4.03 USD | -0.49% | +10.71% | +30.84% | +8.33% | 335.28 M USD | ||
| 3286 | VNDA Vanda Pharmaceuticals Inc. - Common Stock | 5.28 USD | 0.00% | +1.15% | +1.93% | -4.52% | 319.24 M USD | ||
| 3332 | NMRA Neumora Therapeutics, Inc. - Common Stock | 1.60 USD | -1.84% | +6.67% | +5.96% | -1.23% | 300.63 M USD | ||
| 3348 | AVXL Anavex Life Sciences Corp. - Common Stock | 3.12 USD | -3.70% | -1.89% | +29.46% | -67.19% | 289.14 M USD | ||
| 3357 | ACIU AC Immune SA - Common Stock | 2.84 USD | -2.07% | +12.25% | +26.79% | +33.33% | 288.95 M USD | ||
| 3359 | RNAC Cartesian Therapeutics, Inc. - Common Stock | 10.21 USD | +1.69% | +10.98% | +27.78% | +11.46% | 308.91 M USD | ||
| 3364 | FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.82 USD | -0.26% | +1.06% | +1.60% | -44.48% | 291.46 M USD | ||
| 3382 | FATE Fate Therapeutics, Inc. - Common Stock | 2.39 USD | +2.58% | -9.47% | -4.02% | +104.27% | 286.37 M USD | ||
| 3401 | SRZN Surrozen, Inc. - Common Stock | 23.62 USD | -1.54% | -0.46% | +16.13% | +105.57% | 277.62 M USD | ||
| 3402 | TRDA Entrada Therapeutics, Inc. - Common Stock | 7.35 USD | -2.91% | +1.24% | +23.53% | +5.45% | 286.18 M USD | ||
| 3403 | TTRX Turn Therapeutics Inc. - Common Stock | 9.62 USD | +1.69% | +0.10% | +11.99% | -3.80% | 286.56 M USD | ||
| 3407 | ZNTL Zentalis Pharmaceuticals, Inc. - common stock | 3.82 USD | -0.26% | +1.33% | -12.39% | +92.93% | 273.79 M USD | ||
| 3414 | ALXO ALX Oncology Holdings Inc. - Common Stock | 1.99 USD | -2.45% | +2.58% | -1.97% | +63.11% | 275.17 M USD | ||
| 3420 | LCTX Lineage Cell Therapeutics, Inc. Common Stock | 1.09 USD | 0.00% | +0.93% | +3.81% | -36.63% | 275.67 M USD | ||
| 3422 | ELDN Eledon Pharmaceuticals, Inc. - Common Stock | 3.33 USD | -3.48% | -6.46% | -9.51% | +26.14% | 270.60 M USD | ||
| 3424 | IVVD Invivyd, Inc. - Common Stock | 0.93 USD | -7.00% | +27.40% | +52.46% | +75.47% | 274.13 M USD |
Nachrichten Biotechnology Stocks
Alto Neuroscience Aktie erreicht Allzeithoch bei 35,42 USD
Deutsche Bank stuft Argenx Aktie wegen Bewertung auf ’Hold’ herab
Klinischer Meilenstein ohne Kursschub: Aktie von Monte Rosa Therapeutics unter Druck
Biomea Fusion Aktie mit Kurssprung nach Abschluss der Rekrutierung für Diabetes-Studie
Monte Rosa Aktie fällt nach Start von Phase-2-Studie zu Prostatakrebs
ROUNDUP/Aktien New York: Chipwerte belasten Nasdaq kräftig - Dow leicht im Plus
Crinetics Pharmaceuticals Aktie erreicht Allzeithoch bei 84,8 USD
Gainers Biotechnology Stocks
SKYE Skye Bioscience, Inc. - Common Stock | 2.06 | +635.71% |
ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
APRE Aprea Therapeutics, Inc. - Common Stock | 0.78 | +21.88% |
GOSS Gossamer Bio, Inc. - Common Stock | 0.18 | +20.00% |
BMEA Biomea Fusion, Inc. - Common Stock | 1.59 | +16.06% |
LSTA Lisata Therapeutics, Inc. - Common Stock | 1.76 | +13.55% |
NTRB Nutriband Inc. - Common Stock | 5.29 | +13.28% |
CRDF Cardiff Oncology, Inc. - Common Stock | 0.98 | +11.36% |
Losers Biotechnology Stocks
HUMAW Humacyte, Inc. - Warrant | 0.0041 | -54.44% |
CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
RGNX REGENXBIO Inc. - Common Stock | 8.21 | -23.41% |
ADXN Addex Therapeutics Ltd - American Depositary Shares | 3.89 | -21.26% |
CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.0928 | -15.48% |
ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.31 | -14.63% |
BCTX BriaCell Therapeutics Corp. - Common Shares | 3.50 | -14.00% |
APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |